Identifying proteins that influence breast cancer risk
Identification of proteins for breast cancer risk: an integrative epidemiologic and genomic study
This study is looking at how certain proteins might be connected to breast cancer risk by examining genetic information from both healthy women and those with breast cancer, with the hope of finding new ways to prevent and treat the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10973013 on NIH RePORTER |
What this research studies
This research aims to uncover the proteins linked to breast cancer risk by analyzing genetic data from a large population. It utilizes existing samples from cancer-free women and breast cancer patients to identify target proteins that may play a role in the disease. By focusing on proteins rather than just genetic information, the study seeks to provide a clearer understanding of the biological mechanisms behind breast cancer. This approach could lead to better prevention and treatment strategies for the disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include women with a family history of breast cancer or those concerned about their genetic risk factors.
Not a fit: Patients who have already been diagnosed with breast cancer may not directly benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for predicting and preventing breast cancer.
How similar studies have performed: Previous research has successfully identified genetic factors associated with breast cancer, but this proteogenomics approach is relatively novel and untested.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Long, Jirong — Vanderbilt University Medical Center
- Study coordinator: Long, Jirong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.